NeuroBionics
Private Company
Total funding raised: $40M
Overview
NeuroBionics is a private, pre-revenue biotech firm founded in 2017 and based in Austin, Texas. The company has developed a proprietary platform of microscale, multifunctional bioelectronic fibers designed for seamless integration with neural tissue. Its lead clinical program, evStim, aims to revolutionize deep brain stimulation (DBS) by enabling endovascular delivery, while its IO fiber serves as a research tool for neuroscience. Backed by foundational MIT research and industry leaders, NeuroBionics is positioned at the intersection of medical devices and regenerative medicine.
Technology Platform
Microscale, flexible, bioelectronic fibers capable of multifunctional (electrical, optical, chemical, mechanical) neural interfacing for minimally invasive integration with the body.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
NeuroBionics competes with traditional DBS device makers (Medtronic, Abbott, Boston Scientific) and a growing field of neurotech startups exploring less invasive interfaces (e.g., Synchron, Paradromics). Its differentiation lies in its unique fiber-based, multifunctional, and endovascular approach.